Back to Guavy Wire

Stocks

Edgestream Partners Boosts Stake in Amgen Amid Institutional Investor Shakeup

Guavy AI Editorial Team Published August 2, 2026

Instruments

AMGN

Edgestream Partners L.P., an investment firm, has increased its stake in Amgen Inc. by 169.9% in the first quarter, according to a recent SEC filing.

The firm now owns 8,376 shares of Amgen's stock, valued at $2,947,000.

This is not an isolated incident, as other institutional investors have also made significant changes to their holdings of AMGN.

For example, Dogwood Wealth Management LLC boosted its holdings in Amgen by 275.0% in the fourth quarter and now owns 75 shares valued at $25,000.

More on Stocks

Stocks just now

IBM Stocks Plummet Amid Mainframe Revenue Drop, Management Stays Bullish

Stocks just now

Groupama Asset Management Sells Thousands of IBM Shares

Stocks just now

$694K Investment in IBM: WNY Asset Management Enters Tech Giant

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy